Status:
COMPLETED
Ultrasound Guided Supraclavicular Nerve Block
Lead Sponsor:
The Cleveland Clinic
Conditions:
Local Anesthetic
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
This study will test the hypothesis that sequential injection of 1.5% mepivacaine followed 90 seconds later by 0.5% ropivacaine in ultrasound guided supraclavicular block provides a quicker onset and ...
Detailed Description
Patients will be randomized into one of two groups, Group M: Ropivacaine and Mepivacaine - subject will receive two injections before surgery begins. These two injections will consist of the mixture o...
Eligibility Criteria
Inclusion
- Patients undergoing upper extremity procedures suitable for supraclavicular anesthesia, including but not limited to oHand surgery oForearm surgery oElbow surgery
- Age between 18 and 70 years
Exclusion
- Contraindications to supraclavicular block
- Coagulopathy
- Infection at the needle insertion site
- Severe chronic obstructive pulmonary disease (COPD)
- Contralateral pneumothorax or diaphragmatic paralysis
- Pregnancy
- Preexisting neuropathy involving the surgical limb
- Routine opioid use
- Inability to attain adequate ultrasound images in the supraclavicular area
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00825786
Start Date
September 1 2008
End Date
August 1 2010
Last Update
June 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195